OR WAIT null SECS
December 13, 2022
Amgen’s $27.8 billion acquisition of Horizon Therapeutics, an Irish biotechnology company, is one of the largest of 2022.
December 07, 2022
The partnership will see the pharma giants partner with researchers from A*STAR and various Singapore universities.
December 02, 2022
Pharmaceutical Technology Europe got the scoop on Agilent's new Dissolution Testing Centre of Excellence in Craven Arms, UK.
Anti-obesity drugs have the potential to be the next blockbusters, according to market analysis.
December 01, 2022
Merck will use BigHat’s AI/machine learning-enabled platform to design candidates for up to three drug discovery programs.
November 30, 2022
AstraZeneca inked a deal worth up to $320 million to purchase Neogene Therapeutics, a biotech start-up focused on T-cell receptor therapies.
The agreement will see Immutep and Merck KGaA, Darmstadt, Germany jointly fund the INSIGHT-005 study.
November 28, 2022
Merck will purchase Imago BioSciences, a biotechnology company focused on bone marrow disorders, for approximately $1.35 billion.
November 22, 2022
The collaboration will see the companies develop investigational next-generation bispecific immunotherapies for cancer.
November 21, 2022
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.